Donna A. Volpe
- Oncology top 5%
- Molecular Biology
- Pharmacology top 1%
- Dermatology top 2%
- Pharmaceutical Science top 1%
- Co-authors
- Charles K. GrieshaberRobert ParkerAnne‐Marie TobinMartin J. MurphyR. Daniel MellonTimothy J. KroppThomas ColatskyPatrick J. Faustino
- Topics
- Drug Transport and Resistance Mechanisms (17 papers)Pharmacogenetics and Drug Metabolism (14 papers)Pharmacological Effects and Toxicity Studies (10 papers)
- Partner nations
- United StatesThailandSweden
In The Last Decade
Donna A. Volpe
60 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Oncology 613
- Molecular Biology 588
- Pharmacology 286
- Dermatology 280
- Pharmaceutical Science 280
Countries citing papers authored by Donna A. Volpe
This map shows the geographic impact of Donna A. Volpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna A. Volpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna A. Volpe more than expected).
Fields of papers citing papers by Donna A. Volpe
This network shows the impact of papers produced by Donna A. Volpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna A. Volpe. The network helps show where Donna A. Volpe may publish in the future.
Co-authorship network of co-authors of Donna A. Volpe
This figure shows the co-authorship network connecting the top 25 collaborators of Donna A. Volpe. A scholar is included among the top collaborators of Donna A. Volpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna A. Volpe. Donna A. Volpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 15 | |
| 4 | 13 | |
| 5 | 8 | |
| 6 | 14 | |
| 7 | 24 | |
| 8 | 4 | |
| 9 | 31 | |
| 10 | 56 | |
| 11 | 81 | |
| 12 | 1 | |
| 13 | 49 | |
| 14 | 179 | |
| 15 | 63 | |
| 16 | 54 | |
| 17 | 36 | |
| 18 | 21 | |
| 19 | 14 | |
| 20 | 10 |
About Donna A. Volpe
Donna A. Volpe is a scholar working on Pharmacology, Pharmaceutical Science and Oncology, having authored 62 papers that have together received 2.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Pharmacological Effects and Toxicity Studies (10 papers). The work is most often cited by research in Pharmaceutical Science (280 citations), Pharmacology (286 citations) and Dermatology (280 citations). Donna A. Volpe has collaborated with scholars based in United States, Thailand and Sweden. Frequent co-authors include Charles K. Grieshaber, Robert Parker, Anne‐Marie Tobin, Martin J. Murphy, R. Daniel Mellon, Timothy J. Kropp, Thomas Colatsky, Patrick J. Faustino, S. Leigh Verbois and Aspandiar G. Katki. Their work appears in journals such as JAMA, PLoS ONE and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.